March 6, 2022
1 min read

Pharma sector expected to grow between 6 and 8 % YoY in FY23

The agency said that higher Capex in lieu of the ‘Production-linked Incentives’ (PLI) scheme will restrict the quantum of free cash flow generation during the year….reports Asian Lite News

India’s pharmaceuticals market (IPM) is expected to grow between 6 and 8 per cent on a year-on-year (YoY) basis in FY23.

Accordingly, the growth has been capped due to high base effect and inventory stocking in FY21 on account of Covid-19-led disruption in supplies of key starting materials.

Besides, API (Active Pharmaceuticals Ingredient) businesses are expected to report high single-digit growth in FY23 due to a demand uptick, the overall revenue growth is expected at 9-to-10 per cent YoY.

In a research note, India Ratings and Research (Ind-Ra) said it has maintained a neutral outlook for the Indian pharmaceutical sector for FY23.

The agency said that higher Capex in lieu of the ‘Production-linked Incentives’ (PLI) scheme will restrict the quantum of free cash flow generation during the year.

pharma industry

“Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities,” the note said.

“Cost-cutting measures remain a priority for Indian companies. However, interim disruptions such as high raw material costs and logistic expenses will put pressure on the level of free cash flow generated.”

Besides, the agency said that with the significant improvement in the free cash flow generated in the near term, M&A activities will continue to provide inorganic push in FY23.

“Ind-Ra does not expect the sector’s liquidity to face a major risk, despite similar maturities levels in FY23 and FY24. Large pharma companies generally have large cash balances, which typically account for 14-16 per cent of their revenue.”

Furthermore, most companies have sufficient headroom under debt covenants and diversified funding sources.

“The interest coverage of large pharma players is likely to increase with scale and margin expansion.”

“Ind-Ra expects large pharma companies to continue with their healthy debt-funded capex and research and development programme, given higher visibility in terms of sales growth and profitability.”

ALSO READ: AYYA T1: Russian’s alternative to iPhone

Previous Story

Tesla receives environmental nod to produce EVs at Gigafactory Berlin

Next Story

Melbourne Cricket Ground to be renamed after Shane Warne

Latest from India News

India, Oman Cement Defence Partnership

The officials of two nations also held talks on capability development, professional military education and new avenues for partnership…reports Asian Lite News The Indian Army and Royal Army of Oman held the

Jaishankar to Represent PM Modi at East Asia Summit

The East Asia Summit will provide an opportunity to deliberate on the challenges to peace, stability and prosperity in the Indo-Pacific region…reports Asian Lite News External Affairs Minister S. Jaishankar will attend

India drives education forward in Nepal

India donates 81 school buses to Nepal, bolsters education, disaster preparedness, and regional ties; parliamentary delegations engage on diplomacy, climate, AI, and humanitarian cooperation at IPU Assembly….reports Asian Lite News In a

Nag Mark-2 locks on!

India’s defence modernisation drive gains momentum with upcoming clearance for Nag Mark-2 missiles and a ₹10,000 crore S-400 missile deal with Russia, boosting both self-reliance and deterrence….reports Asian Lite News In a

Trump won’t drop his ‘Modi oil’ story

US President Trump once again claimed Prime Minister Modi promised to cut Russian oil imports by year-end, even as India denies any recent call or commitment, stressing energy independence. United States President
Go toTop

Don't Miss

Indian High Commission in the UK Celebrates New Year

The video featured members of the Indian Mission in London

Nepal to export 40 MW power to Bangladesh through Indian grid

Significant agreements encompassing connectivity, commerce and power sector were signed